Form 4 for ASBP Aspire Biopharma Holdings, Inc.
Accepted 2025-06-06 00:00:00 ET · period of report 2025-06-04 · accession 0001641172-25-014102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-06 | 2025-06-04+ | ASBP | Fell Donald G. | Dir | P - Purchase | $0.39 | -20.0K | 20.0K | -50% | -$7,800 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2025-06-04 | P | D | 9,500 | $0.39 | 9,500 | D | — | — | |
| 2 | Common | Common Stock, par value $0.0001 | 2025-06-05 | P | D | 10,500 | $0.39 | 20,000 | D | — | — |